We developed a unified process platform for two recombinant human GCSF medicines--one with the non-prolonged and the other with prolonged action. This unified technology led to a simpler and cheaper production while introduction of the additional pegylation stage to the technological line eased obtaining of the medicines with different action and allowed to standardize technological process documenting according to GMP requirements.
View Article and Find Full Text PDFIn order to create an active pharmaceutical substance of the drug with prolonged action the modification of recombinant human granulocyte colony-stimulating factor GCSF (filgrastim) with polyethylene glycol (PEG, M 21.5 kDa) was conducted. A method for preparation of PEG-filgrastim designed for the development and scaling-up of the technological process of production was described.
View Article and Find Full Text PDFThe paper presents general approaches to solving the problems associated with the radioecological safety of radioactive waste (RAW) storages. It considers the influence of climatic factors on the possible release of radionuclides into the environment. The authors have made as follows: analysis of the significance of main scenarios for radionuclide release into the environment and the natural and climatic conditions of the existing areas of near-surface RAW storages in the Russian Federation; conditional zoning of the Russian Federation according to the balance of atmospheric precipitation.
View Article and Find Full Text PDFThe article contains data on changed state of natural (geologic) barrier in construction and running the depots for radioactive waste. The authors stress over 10-fold increased water-permeability of upper part of radioactive waste placement ground, formation of antropogenous (technogenic) water-bearing level and changed filtration flow direction. Based on radionuclides migration modelling, the authors determined possibility of more intensive relocation of radionuclides in subsoil.
View Article and Find Full Text PDFProbl Tuberk Bolezn Legk
June 2009
A new reagent for a skin test given the name Diaskintest has been designed for the screening diagnosis of tuberculosis and preclinical and clinical trials conducted. Preclinical trials were carried out on 315 laboratory animals (guinea-pigs, albino mice). The reagent Diaskintest was ascertained to be nontoxic, to have no sensitizing properties, to be safe and specific, and to induce no positive reactions in BCG-vaccinated animals and healthy guinea-pigs.
View Article and Find Full Text PDFFiziol Zh SSSR Im I M Sechenova
September 1974
Fiziol Zh SSSR Im I M Sechenova
November 1973
Fiziol Zh SSSR Im I M Sechenova
May 1973
Fiziol Zh SSSR Im I M Sechenova
September 1972
Zh Vyssh Nerv Deiat Im I P Pavlova
April 1972